These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 27476823)

  • 1. Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma.
    Vescovo T; Refolo G; Vitagliano G; Fimia GM; Piacentini M
    Clin Microbiol Infect; 2016 Oct; 22(10):853-861. PubMed ID: 27476823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying the Hepatitis C Virus-Induced Epigenetic Signature After Cure with Direct-Acting Antivirals.
    Perez S; Gal-Tanamy M
    Methods Mol Biol; 2019; 1911():191-207. PubMed ID: 30593627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection.
    Yamashita T; Honda M; Kaneko S
    J Gastroenterol Hepatol; 2011 Jun; 26(6):960-4. PubMed ID: 21443660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis.
    Takeda H; Takai A; Inuzuka T; Marusawa H
    J Gastroenterol; 2017 Jan; 52(1):26-38. PubMed ID: 27714455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
    Perez S; Kaspi A; Domovitz T; Davidovich A; Lavi-Itzkovitz A; Meirson T; Alison Holmes J; Dai CY; Huang CF; Chung RT; Nimer A; El-Osta A; Yaari G; Stemmer SM; Yu ML; Haviv I; Gal-Tanamy M
    PLoS Genet; 2019 Jun; 15(6):e1008181. PubMed ID: 31216276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.
    Wirth TC; Manns MP
    Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C Virus Mediated Metastasis in Hepatocellular Carcinoma as a Therapeutic Target for Cancer Management.
    Khera L; Paul C; Kaul R
    Curr Drug Metab; 2018; 19(3):224-235. PubMed ID: 29380693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
    Koike K
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C virus infection and hepatocarcinogenesis].
    Berta E; Egresi A; Bacsárdi A; Gáspár Z; Lengyel G; Hagymási K
    Orv Hetil; 2019 Jun; 160(22):846-853. PubMed ID: 31131608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.
    Virzì A; Roca Suarez AA; Baumert TF; Lupberger J
    Cold Spring Harb Perspect Med; 2020 Jan; 10(1):. PubMed ID: 31501266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C Virus-Associated Cancers.
    Yi Z; Yuan Z
    Adv Exp Med Biol; 2017; 1018():129-146. PubMed ID: 29052135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C virus infection and hepatocarcinogenesis].
    Szalay F
    Orv Hetil; 2010 Sep; 151(38):1524-9. PubMed ID: 20826376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-associated cancer.
    Lin MV; King LY; Chung RT
    Annu Rev Pathol; 2015; 10():345-70. PubMed ID: 25387053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic viruses and hepatocellular carcinoma.
    Ben Ari Z; Weitzman E; Safran M
    Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer.
    McGivern DR; Lemon SM
    Oncogene; 2011 Apr; 30(17):1969-83. PubMed ID: 21258404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip.
    Goto K; Roca Suarez AA; Wrensch F; Baumert TF; Lupberger J
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA in HCV infection and liver cancer.
    Kumar A
    Biochim Biophys Acta; 2011; 1809(11-12):694-9. PubMed ID: 21821155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HCV mutated proteins and host SNPs in the development of hepatocellular carcinoma.
    Suhail M; Sohrab SS; Qureshi A; Tarique M; Abdel-Hafiz H; Al-Ghamdi K; Qadri I
    Infect Genet Evol; 2018 Jun; 60():160-172. PubMed ID: 29501636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.